These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Double-blind controlled crossover high-dose study of Azaribine in psoriasis.
    Author: Crutcher WA, Moschella SL.
    Journal: Br J Dermatol; 1975 Feb; 92(2):199-205. PubMed ID: 1096923.
    Abstract:
    Azaribine used in high doses of 200 mg/kg a day is an effective agent in inducing temporary remissions in patients with severe psoriasis but potentially serious neurotoxicity may occur. Therapy should be initiated at lower doses of 125 mg/kg a day and advanced carefully only if clinical response does not ensue at the lower level.
    [Abstract] [Full Text] [Related] [New Search]